Imagia Appoints Geralyn Ochab as Chief Executive Officer

Montréal, September 2, 2020  Imagia, a leading healthcare AI company that unites healthcare expertise and advanced artificial intelligence technology, is pleased to announce that the company’s Board of Directors has appointed Mrs. Geralyn Ochab as Chief Executive Officer.

‘’I am very pleased to have the opportunity to lead this outstanding organization of remarkable people leveraging important and leading edge technology to realize Imagia’s optimal potential’’ says Mrs. Ochab.  “Collectively, our key objectives are to drive shareholder value and to be thoughtfully and purposefully executing our strategy at a velocity that meets what our industry demands”.

With a proven executive management track record with more than 25 years as an innovative healthcare technology leader, Mrs. Ochab brings exceptional accomplishments in entrepreneurial start-ups to large corporate entities. She has extensive experience in forming corporate alliances, developing and managing strategic opportunities and successfully leading mergers and acquisitions. Most recently, she served as Chief Business Officer at Imagia, where she led the strategy and execution of industry-first commercial and collaboration agreements. She also served as Vice President Business Development, at Insception-Lifebank Cord Blood stem cell bank where she significantly grew annual revenues in the direct-to-patient consumer healthcare business. Her reputation of an empowered leader builds trust and excellence in high-performing teams.

Jean-François Pariseau, Chair of Imagia and Co-Founding Partner at Amplitude Ventures says the Board of Directors is delighted to have Ochab as its next CEO. ‘’We are pleased to have Geralyn step into the role of Chief Executive Officer to bring the company to its next level of growth. With her deep knowledge of the healthcare industry coupled with her strong command of business acumen and proven ability to drive results, she is the right person to lead Imagia during the crucial time in the AI Industry”.

About Imagia

Imagia, an AI healthcare company, develops digital medical innovations that improve the health of cancer patients and those afflicted with other high-burden diseases. Through its collaborative ecosystem, Imagia EVIDENSTM enables hospitals, medical device manufacturers, pharmaceutical companies, and diagnostic companies around the world to access and utilize healthcare data while preserving data privacy. The company’s head office is located in Montreal, Canada.

Media Contact:

Elpi Klapa
Marketing Director
[email protected]
1+514.652.3574

Related posts

Imagia Partners with Illumina to Scale Discoveries Across Genomic and Clinical Data

Imagia Partners with Illumina to Scale Discoveries Across Genomic and Clinical Data

Advanced AI-discovery platform Imagia EVIDENS™ to link analysis of genomic data to patient outcomes for reproducible data-driven precisi

...
Read more
“Federal Government Awards $49M to Terry Fox Research Institute and Imagia led Consortium to Accelerate Medical Breakthroughs“

“Federal Government Awards $49M to Terry Fox Research Institute and Imagia led Consortium to Accelerate Medical Breakthroughs“

The Honourable Navdeep Bains, Minister of Innovation, Science and Economic Development, announced an investment of up to $49M from the Strat

...
Read more
$2.6M to fight cancer using innovative technologies and artificial intelligence

$2.6M to fight cancer using innovative technologies and artificial intelligence

Created by leading financiers wanting to combine academic research and industry expertise, the Onco-Tech Competition is an opportunity for Q

...
Read more